paroxetine

(redirected from Paroxetine mesylate)
Also found in: Medical.
Related to Paroxetine mesylate: Paxil

par·ox·e·tine

 (pă-rŏk′sĭ-tēn′)
n.
A drug of the SSRI class, C19H20FNO3, used in its hydrochloride form to treat depression, anxiety, and certain other disorders, including obsessive-compulsive disorder.

[par(a)- + ox(y)- + (m)et(hyl) + (piperid)ine.]

paroxetine

(pæˈrɒksətiːn)
n
(Pharmacology) an antidepressant drug that acts by preventing the re-uptake after release of serotonin in the brain, thereby prolonging its action: used for treating depression, obsessive-compulsive disorders, and panic disorder. Formula: C19H20FNO3
Translations

paroxetine

n paroxetina
Mentioned in ?
References in periodicals archive ?
The majority of a Food and Drug Administration advisory panel recommended against approval of a low-dose formulation of paroxetine mesylate as a treatment for menopausal vasomotor symptoms, citing minimal benefits over placebo in clinical trials and the potential risks associated with treatment.
Adverse effects after switching to a different generic form of paroxetine: Paroxetine mesylate instead of paroxetine KCI hemihydrate [in Dutch].
European clinicians have employed paroxetine mesylate from Synthon for about three years, with over 60 million tablets sold.
The US Food and Drug Administration recently approved paroxetine mesylate (Brisdelle) for the treatment of postmenopausal vasomotor symptoms.
Bioequivalent to Paxil, the blockbuster antidepressant from GlaxoSmithKline, which is formulated as paroxetine hydrochloride, Pexeva contains paroxetine mesylate.